TZ-Ab102

N/A

Report date: 2025/11/24 11:12:13

Base Information

Drug NameTZ-Ab102

Drug Alias NameTZ-Ab102

ClassificationBiologics > Protein drugs

Mechanisms of ActionWilms' Tumour 1 inhibitors

TargetsWilms' Tumour 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTherazyne Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesTherazyne Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A